Streetbeat News

Partnerships

FFNTF

FLGC

MMNFF

OGI

SBIG

January saw significant executive and board changes in the cannabis industry. Flora Growth Corp.'s CEO, Clifford Starke, was elected chairman of the U.S. Hemp Roundtable. 4Front Ventures and The Cannabist Company Holdings announced new CEOs. Organigram Holdings and other companies made board appointments, while MedMen Enterprises and BZAM Ltd. saw departures. Trulieve Cannabis appointed a new COO, and other companies expanded their executive teams.

Portfolio Pulse from Jelena Martinovic

February 02, 2024 | 4:01 pm

GEF

Greif, Inc. has announced a partnership with the Columbus Blue Jackets, an NHL franchise. This collaboration aims to enhance Greif's brand visibility and community engagement through various initiatives with the hockey team.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:35 pm

AAPL

AMZN

GOOGL

META

PUB

TSLA

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin remain strong amid US banking concerns. US charges individuals in a $400M hack, and arrests are made related to BTC-e for money laundering. Apple's Q1 results lead to a pre-market drop, while Meta's stock surges 16% premarket. Investor optimism boosts the Dow by over 350 points. Global demand for AI infrastructure is highlighted by Nvidia's CEO. Amazon continues layoffs despite profits, and Google expands AI features globally. Tesla recalls Cybertrucks, and GM focuses on EV production. Publicis settles in opioid marketing case, and commercial real estate issues affect regional banking stocks.

Portfolio Pulse from Akanksha Bakshi

February 02, 2024 | 2:39 pm

SIDU

Sidus Space, Inc. (SIDU) has announced its membership in the Solis Applied Science, LLC team, which was selected by the National Geospatial-Intelligence Agency (NGA) to provide research and development services to NGA's Research and Development Directorate. This collaboration highlights Sidus Space's involvement in significant government contracts and its role in advancing geospatial intelligence and research.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 1:31 pm

CALC

FGEN

ORMP

PEPG

Four health care stocks, PepGen Inc. (PEPG), CalciMedica, Inc. (CALC), Oramed Pharmaceuticals Inc. (ORMP), and FibroGen, Inc. (FGEN), are considered overbought as of Feb. 2, 2024, based on their RSI values. Recent developments and price actions for each company are highlighted, with PEPG and FGEN showing significant gains, while CALC and ORMP experienced declines.

Portfolio Pulse from Avi Kapoor

February 02, 2024 | 1:21 pm

WNS

WNS Holdings Ltd. announced that one of its top five customers by revenue contribution in the HCLS SBU has issued a termination notice effective July 1, 2024. This customer accounted for a significant portion of WNS's revenue over the past three fiscal years. Despite the termination, WNS stated it will not impact their fiscal 2024 revenue and discussions are ongoing regarding the transition of services.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 1:08 pm

JFBR

Jeffs' Brands announced that its unit, Fort Products, has secured an exclusive distribution agreement for solar panel protection. This agreement positions Jeffs' Brands (JFBR) to potentially increase its market share in the renewable energy sector.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:37 pm

ENV

NAAS

NaaS Technology announced it has received an investment from Envestnet, a major player in the turnkey asset management program (TAMP) sector, through Envestnet's mutual fund. This strategic investment signifies a notable collaboration between a leading technology service provider in the energy sector and a giant in financial asset management.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:12 pm

PLUG

Plug Power announced it has signed a BEDP contract for a 500MW electrolyzer project in Europe, marking a significant expansion in its hydrogen production capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 12:10 pm

CATX

EXFY

PCSA

RVP

Insiders are buying shares in four US-listed companies under $3: Retractable Technologies, Expensify, Perspective Therapeutics, and Processa Pharmaceuticals. These transactions indicate insider confidence in the companies' prospects. Retractable Technologies reported a loss, while Expensify received a price target upgrade. Perspective Therapeutics signed a licensing agreement, and Processa Pharmaceuticals announced a public offering.

Portfolio Pulse from Avi Kapoor

February 02, 2024 | 12:09 pm